FIELD: pharmaceutical industry, in particular agents for viral disease treatment including HIV infection (AIDS and HIV-associated diseases).
SUBSTANCE: claimed agent in form of suppository contains per one 2 g suppository Fullevir (fullerenopolyaminocaproic acid sodium salt) 20 mg as active ingredient and ancillary substances such as propylene glycol 200 mg and balance: Vitepsol.
EFFECT: effective agent having no adverse influence on peripheral blood and body systems.
| Title | Year | Author | Number |
|---|---|---|---|
| HYDRATED N-FULLERENE-AMINO ACID DERIVATIVES, METHOD FOR PREPARING THEM AND BASED PHARMACEUTICAL COMPOSITIONS | 2011 |
|
RU2458046C1 |
| ANTI-VIRAL AGENT FOR SYSTEMIC APPLICATION | 2006 |
|
RU2316321C1 |
| ANTIVIRAL MEDICINE | 2007 |
|
RU2333751C1 |
| HOMO- AND HETERO-POLYAMINO ACID FULLERENE C DERIVATIVES, METHOD FOR PREPARING THEM AND BASED PHARMACEUTICAL COMPOSITIONS | 2011 |
|
RU2458914C1 |
| ANTIVIRAL MEDICINE | 2007 |
|
RU2333753C1 |
| SILVER SALT OF N-(6-METHYL-2,4-DIOXO-1,2,3,4-TETRAHYDRO-5H-PYRIMIDINESULPHONE)-N'-ISONICOTINOYLHYDRAZIDE, WHICH EXHIBITS IMMUNOTROPIC, ANTIMICROBIAL, ANTIFUNGAL (ANTIMYCOTIC) ACTIVITY AND MEDICINAL AGENT BASED ON SAID SALT | 2008 |
|
RU2368609C1 |
| DRUG PREPARATION TILORONE IN SUPPOSITORIES | 2008 |
|
RU2411032C2 |
| PHARMACEUTICAL COMPOSITION FOR TREATMENT OF TYPE 2 DIABETES MELLITUS AND MEDICINE ON ITS BASIS | 2009 |
|
RU2435593C2 |
| PHARMACEUTICAL SALTS OF 3-O-(3',3-DIMETHYLSUCCINYL) BETULINIC ACID | 2005 |
|
RU2387665C2 |
| ANTIVIRAL MEDICINE | 2007 |
|
RU2333752C1 |
